A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
מצבים רפואיים
EDS · Cataplexy · Fatigue · Narcolepsy
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Phoenix Medical Group, PC, Peoria, Arizona, United States
Contact: Principal Investigator (Robert Orr, DO)Santa Monica Clinical Trials, Los Angeles, California, United States
Contact: Principal Investigator (Daniel Norman, MD)Alpine Clinical Research Center, Inc, Boulder, Colorado, United States
Contact: Principal Investigator (John R Harsh, PhD)PharmaDev Clinical Research Institute, LLC, Miami, Florida, United States
Contact: Principal Investigator (Edward Mezerhane, MD)Central Florida Pediatric Sleep Disorders Institute, Winter Park, Florida, United States
Contact: Principal Investigator (Akinyemi O Ajayi, MD)Neurotrials Research Inc, Atlanta, Georgia, United States
Sleep Practitioners, LLC, Macon, Georgia, United States
Contact: Principal Investigator (Charles C Wells, Jr, MD)Intrepid Research, LLC, Cincinnati, Ohio, United States
Contact: Principal Investigator (Bruce C Corser, MD)Respiratory Specialists, Wyomissing, Pennsylvania, United States
Contact: Principal Investigator (Alec Platt, MD)Lowcountry Lung and Critical Care PA, Charleston, South Carolina, United States
Contact: Principal Investigator (Thomas D Kaelin Jr, DO)Bogan Sleep Consultants, LLC, Columbia, South Carolina, United States
Contact: Principal Investigator (Richard Bogan, MD)Southwest Family Medicine, Dallas, Texas, United States
Contact: Principal Investigator (Chrisette Dharma, MD)Sleep Therapy & Research Center, San Antonio, Texas, United States
Contact: Principal Investigator (Nagwa Lamaie, MD)Sleep and Performance Research Center, Spokane, Washington, United States
Contact: Principal Investigator (Devon Hansen, PhD)
מובילי המחקר
David Seiden, MD
Study Director
Harmony Biosciences Management, Inc.